Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 1
1992 1
1994 2
1995 2
1996 1
1997 2
1998 3
2000 1
2001 1
2002 1
2003 2
2004 3
2006 1
2007 3
2008 2
2009 1
2010 4
2011 2
2012 6
2013 9
2014 5
2015 8
2016 2
2017 4
2018 10
2019 9
2020 10
2021 18
2022 7
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

110 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C, Schwartz H, Neuzil K, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Mascola J, Polakowski L, Ledgerwood J, Graham BS, Bennett H, Pajon R, Knightly C, Leav B, Deng W, Zhou H, Han S, Ivarsson M, Miller J, Zaks T; COVE Study Group. Baden LR, et al. N Engl J Med. 2021 Feb 4;384(5):403-416. doi: 10.1056/NEJMoa2035389. Epub 2020 Dec 30. N Engl J Med. 2021. PMID: 33378609 Free PMC article. Clinical Trial.
Current approaches to hepatic encephalopathy.
Vidal-Cevallos P, Chávez-Tapia NC, Uribe M. Vidal-Cevallos P, et al. Ann Hepatol. 2022 Nov-Dec;27(6):100757. doi: 10.1016/j.aohep.2022.100757. Epub 2022 Sep 14. Ann Hepatol. 2022. PMID: 36115576 Free article. Review.
Even though minimal HE has negative effects on the patient's quality of life and effects on prognosis, indications for treatment are still controversial. There are still many unanswered questions regarding the pathophysiology and management of HE. ...
Even though minimal HE has negative effects on the patient's quality of life and effects on prognosis, indications for treatment are …
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
El Sahly HM, Baden LR, Essink B, Doblecki-Lewis S, Martin JM, Anderson EJ, Campbell TB, Clark J, Jackson LA, Fichtenbaum CJ, Zervos M, Rankin B, Eder F, Feldman G, Kennelly C, Han-Conrad L, Levin M, Neuzil KM, Corey L, Gilbert P, Janes H, Follmann D, Marovich M, Polakowski L, Mascola JR, Ledgerwood JE, Graham BS, August A, Clouting H, Deng W, Han S, Leav B, Manzo D, Pajon R, Schödel F, Tomassini JE, Zhou H, Miller J; COVE Study Group. El Sahly HM, et al. N Engl J Med. 2021 Nov 4;385(19):1774-1785. doi: 10.1056/NEJMoa2113017. Epub 2021 Sep 22. N Engl J Med. 2021. PMID: 34551225 Free PMC article. Clinical Trial.
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico.
Dunkle LM, Kotloff KL, Gay CL, Áñez G, Adelglass JM, Barrat Hernández AQ, Harper WL, Duncanson DM, McArthur MA, Florescu DF, McClelland RS, Garcia-Fragoso V, Riesenberg RA, Musante DB, Fried DL, Safirstein BE, McKenzie M, Jeanfreau RJ, Kingsley JK, Henderson JA, Lane DC, Ruíz-Palacios GM, Corey L, Neuzil KM, Coombs RW, Greninger AL, Hutter J, Ake JA, Smith K, Woo W, Cho I, Glenn GM, Dubovsky F; 2019nCoV-301 Study Group. Dunkle LM, et al. N Engl J Med. 2022 Feb 10;386(6):531-543. doi: 10.1056/NEJMoa2116185. Epub 2021 Dec 15. N Engl J Med. 2022. PMID: 34910859 Free PMC article. Clinical Trial.
Biomarkers of Autoimmune Chronic Spontaneous Urticaria.
Larenas-Linnemann D. Larenas-Linnemann D. Curr Allergy Asthma Rep. 2023 Dec;23(12):655-664. doi: 10.1007/s11882-023-01117-7. Epub 2023 Dec 8. Curr Allergy Asthma Rep. 2023. PMID: 38064133 Review.
Most importantly, their disease generally presents a less aggressive course, a better response to second generation (up-dosed) antihistamines and a good response to omalizumab, if necessary. ...
Most importantly, their disease generally presents a less aggressive course, a better response to second generation (up-dosed) antihi …
Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.
Ramos-Rincón JM, Ventura PS, Casas-Rojo JM, Mauri M, Bermejo CL, de Latierro AO, Rubio-Rivas M, Mérida-Rodrigo L, Pérez-Casado L, Barrientos-Guerrero M, Giner-Galvañ V, Gallego-Lezaun C, Milián AH, Manzano L, Blázquez-Encinar JC, Solís-Marquínez MN, García MG, Lobo-García J, Valente VA, Roig-Martí C, León-Téllez M, Tellería-Gómez P, González-Juárez MJ, Gómez-Huelgas R, López-Escobar A; SEMI-COVID-19 Network. Ramos-Rincón JM, et al. Intern Emerg Med. 2023 Apr;18(3):907-915. doi: 10.1007/s11739-023-03200-3. Epub 2023 Jan 21. Intern Emerg Med. 2023. PMID: 36680737 Free PMC article.
This work aims to validate the RIM Score-COVID in the SEMI-COVID-19 Registry. The RIM Score-COVID is a simple nomogram with high predictive capacity for in-hospital death due to COVID-19 designed using clinical and analytical parameters of patients diagnosed in the first w …
This work aims to validate the RIM Score-COVID in the SEMI-COVID-19 Registry. The RIM Score-COVID is a simple nomogram with high predicti …
Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease.
López-Sánchez GN, Dóminguez-Pérez M, Uribe M, Chávez-Tapia NC, Nuño-Lámbarri N. López-Sánchez GN, et al. Ann Hepatol. 2021 Mar-Apr;21:100212. doi: 10.1016/j.aohep.2020.04.012. Epub 2020 Jun 6. Ann Hepatol. 2021. PMID: 32533953 Free article. Review.
The international consortia, LITMUS by the European Union and NIMBLE by the United States of America, have started a race for the development of hepatic steatosis and steatohepatitis reliable biomarkers to have an adequate diagnosis. MicroRNAs have been proposed as diagnostic and …
The international consortia, LITMUS by the European Union and NIMBLE by the United States of America, have started a race for the developmen …
Superficial mycoses in immunodepressed patients (AIDS).
Ramos-E-Silva M, Lima CM, Schechtman RC, Trope BM, Carneiro S. Ramos-E-Silva M, et al. Clin Dermatol. 2010 Mar 4;28(2):217-25. doi: 10.1016/j.clindermatol.2009.12.008. Clin Dermatol. 2010. PMID: 20347666 Review.
HIV infection has the capacity to distort the epidemiology and clinical course of infectious diseases, producing atypical manifestations and changing diagnoses. ...These infections are frequently different in immunodepressed patients (AIDS), with a modified course o …
HIV infection has the capacity to distort the epidemiology and clinical course of infectious diseases, producing atypical manifestati …
Rhinovirus Type in Severe Bronchiolitis and the Development of Asthma.
Bergroth E, Aakula M, Elenius V, Remes S, Piippo-Savolainen E, Korppi M, Piedra PA, Bochkov YA, Gern JE, Camargo CA Jr, Jartti T. Bergroth E, et al. J Allergy Clin Immunol Pract. 2020 Feb;8(2):588-595.e4. doi: 10.1016/j.jaip.2019.08.043. Epub 2019 Sep 11. J Allergy Clin Immunol Pract. 2020. PMID: 31520837 Free PMC article.
Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.
Larenas-Linnemann DES, Parisi CAS, Ritchie C, Cardona-Villa R, Cherrez-Ojeda I, Cherrez A, Ensina LF, Garcia E, Medina IV, Rodríguez-González M, Caraballo JMS. Larenas-Linnemann DES, et al. Curr Allergy Asthma Rep. 2018 May 9;18(5):33. doi: 10.1007/s11882-018-0787-5. Curr Allergy Asthma Rep. 2018. PMID: 29744661 Review.
RECENT FINDINGS: Omalizumab is effective for the control of urticaria recalcitrant to antihistamines in different populations globally. The ratio of total serum IgE 4-week/baseline 2 can predict response with a high likelihood. In observational real-life trials, doses have …
RECENT FINDINGS: Omalizumab is effective for the control of urticaria recalcitrant to antihistamines in different populations globally. The …
110 results